Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/28156
Title: | Amino acid substitutions in the epstein-barr virus associated oncogene latent membrane protein 1 impact upon the immunogenicity of Nasopharyngeal carcinoma cells | Authors: | SONG ZHENYING | Keywords: | Epstein-Barr Virus, latent membrane protein 1, nasopharyngeal carcinoma, antigen presentation | Issue Date: | 13-Apr-2009 | Citation: | SONG ZHENYING (2009-04-13). Amino acid substitutions in the epstein-barr virus associated oncogene latent membrane protein 1 impact upon the immunogenicity of Nasopharyngeal carcinoma cells. ScholarBank@NUS Repository. | Abstract: | Epstein Barr virus (EBV) is a gamma herpesvirus that is implicated in the development of nasopharyngeal carcinoma (NPC). The control of natural EBV infection is mediated by the CD8+ T-lymphocyte response targeting viral peptides presented on the surface of infected cells in association with MHC class I. In NPC cells, a principle EBV gene product with oncogenic activity is latent membrane protein (LMP1). Whilst an LMP1-specific CD8+ T cell response is detectable in healthy individuals, it is often undetectable in NPC patients. In this study, we provide a mechanistic insight into why the LMP1 associated with NPC cells but not B-lymphocytes is poorly recognised by the human immune system. We show that LMP1 derived from NPC cells contains a number of point mutations and demonstrate that these mutations in LMP1 result in severe impairment in antigen presentation. This has important implications for the treatment of EBV-associated malignancies like NPC. | URI: | https://scholarbank.nus.edu.sg/handle/10635/28156 |
Appears in Collections: | Master's Theses (Open) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
MSc thesis Song Zhenying HT070051X.pdf | 7 MB | Adobe PDF | OPEN | None | View/Download |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.